CVS Health Beats Projections in Second Quarter

Pharmacist and smiling customer in the aisle of a CVS drugstore

Pharmacist and smiling customer in the aisle of a CVS drugstore

The Missouri-based Paradigm Advsrs Ltd Llc has invested 1.24% in CVS Health Corporation (NYSE:CVS). Robert W. Baird maintained the stock with "Buy" rating in Monday, March 4 report. CVS Health had a return on equity of 16.92% and a net margin of 1.91%.

A number of other large investors have also bought and sold shares of the stock. (CVS has approximately 9,900 locations.) At the same time, the company will continue to remodel stores to its new, health-focused store "HealthHub" format. Mosaic Family Wealth LLC now owns 3,247 shares of the pharmacy operator's stock valued at $213,000 after buying an additional 225 shares during the last quarter. Northern Trust Corp increased its holdings in shares of CVS Health by 24.6% in the fourth quarter. Lathrop Investment Management Corp now owns 156,960 shares of the pharmacy operator's stock valued at $8,553,000 after purchasing an additional 6,249 shares in the last quarter. Finally, Horan Capital Advisors LLC. increased its holdings in shares of CVS Health by 48.4% in the 2nd quarter. Moors & Cabot Inc. grew its holdings in shares of CVS Health by 16.4% in the 2nd quarter. Drexel Morgan & Co. lifted its stake in shares of CVS Health by 6.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 13,790,753 shares of the pharmacy operator's stock worth $903,574,000 after buying an additional 3,041,266 shares during the period.

NYSE:CVS opened at $59.29 on Friday.

FILE PHOTO: A logo of CVS Health is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. The firm has a market cap of $75.50 billion, a price-to-earnings ratio of 7.88, a P/E/G ratio of 1.29 and a beta of 0.90. The company has a debt-to-equity ratio of 1.45, a quick ratio of 0.64 and a current ratio of 0.95. The business's 50 day moving average is $55.41.

That translated to adjusted earnings per share of $1.89, which was 20 cents higher than the $1.69 reported a year prior and 17 cents above the high end of the company's guidance, according to a presentation released with the Q2 numbers.

Net sales reached $63.43 billion, up 35% from the year ago-quarter's $46.92 billion, largely because of the Aetna health insurance business CVS acquired.

Revenue in the pharmacy services segment increased to $34.84 billion from $33.43 billion a year before, with the gain attributed to inflation in brand-name drug prices and volume in total pharmacy claims. During the same period in the prior year, the company posted $1.69 EPS. On average, research analysts expect that CVS Health Corp will post 6.95 earnings per share for the current fiscal year. Madison Inv Hldgs invested in 0.09% or 94,685 shares. The ex-dividend date was Wednesday, July 24th. This represents a $2.00 annualized dividend and a dividend yield of 3.49%.

Several brokerages recently weighed in on CVS. BMO Capital Markets set a $63.00 price objective on CVS Health and gave the stock a "hold" rating in a report on Friday, May 3rd. The health Company will look to carry this momentum through the rest of the year.

Among 17 analysts covering CVS Health (NYSE:CVS), 15 have Buy rating, 0 Sell and 2 Hold. The stock presently has a consensus rating of Buy and a consensus target price of $75.14. Before the deal, the benefits group consisted only of its Medicare prescription-drug plan.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.